We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
(+22%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$124M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$95.2M |
| 3 |
Pliant Therapeutics
PLRX
|
+$74.8M |
| 4 |
Microsoft
MSFT
|
+$72.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$56.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$123M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$60.4M |
| 3 |
Emerson Electric
EMR
|
+$55M |
| 4 |
Home Depot
HD
|
+$54.8M |
| 5 |
Comcast
CMCSA
|
+$53.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.44% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Utilities | 1.38% |
| 5 | Industrials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Global Payments
GPN
$22.8B
| $226K | ﹤0.01% |
+2,290
| New | +$235K |
|
477
Senseonics Holdings Inc
SENS
$394M
| $220K | ﹤0.01% |
+14,411
| New | +$198K |
|
478
PetMed Express
PETS
$42.1M
| $219K | ﹤0.01% |
+15,880
| New | +$238K |
|
479
Remitly
RELY
$4.87B
| $218K | ﹤0.01% |
+11,590
| New | +$211K |
|
480
Intuitive Surgical
ISRG
$139B
| $213K | ﹤0.01% |
+624
| New | +$189K |
|
481
Skywest
SKYW
$4.18B
| $211K | ﹤0.01% |
+5,193
| New | +$154K |
|
482
Ezcorp Inc
EZPW
$1.67B
| $209K | ﹤0.01% |
+24,949
| New | +$216K |
|
483
Colgate-Palmolive
CL
$74.3B
| $206K | ﹤0.01% |
+2,677
| New | +$207K |
|
484
CALL
Delta Air Lines
DAL
$58.7B
| $204K | ﹤0.01% |
+4,300
| New | +$159K |
|
485
Rayonier Advanced Materials
RYAM
$593M
| $203K | ﹤0.01% |
+47,537
| New | +$225K |
|
486
ON Semiconductor
ON
$31.1B
| $202K | ﹤0.01% |
2,141
-5,154
| -71% | -$426K |
|
487
Playtika
PLTK
$1.07B
| $202K | ﹤0.01% |
+17,444
| New | +$189K |
|
488
U-Haul Holding Co Series N
UHAL.B
$12.6B
| $201K | ﹤0.01% |
+3,970
| New | +$208K |
|
489
Tyson Foods
TSN
$20.1B
| $184K | ﹤0.01% |
+3,600
| New | +$196K |
|
490
Comtech Telecommunications
CMTL
$51.5M
| $183K | ﹤0.01% |
+20,068
| New | +$215K |
|
|
UBX
491
DELISTED
Unity Biotechnology
UBX
| $179K | ﹤0.01% |
70,000
| – | – |
|
|
QVCGA
492
DELISTED
QVC Group Inc Series A
QVCGA
| $164K | ﹤0.01% |
+3,306
| New | +$149K |
|
493
Clover Health Investments
CLOV
$2.41B
| $162K | ﹤0.01% |
+180,272
| New | +$160K |
|
494
Union Pacific
UNP
$174B
| $161K | ﹤0.01% |
789
-12,376
| -94% | -$2.46M |
|
|
IMPL
495
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $158K | ﹤0.01% |
124,800
| – | – |
|
|
URG
496
Ur-Energy
URG
$564M
| $157K | ﹤0.01% |
+149,881
| New | +$144K |
|
|
NMTR
497
DELISTED
9 Meters Biopharma
NMTR
| $147K | ﹤0.01% |
218,710
-9,200
| -4% | -$8.13K |
|
498
Lifecore Biomedical
LFCR
$176M
| $139K | ﹤0.01% |
+14,405
| New | +$88K |
|
499
Blend Labs
BLND
$357M
| $136K | ﹤0.01% |
+143,601
| New | +$127K |
|
500
Blue Owl Capital
OBDC
$5.7B
| $136K | ﹤0.01% |
+10,123
| New | +$132K |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.
- Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
- Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
- Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
- Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
- Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
- Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
- Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.
Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.